Cantitate/Preț
Produs

Adoptive Cell Transfer: International Review of Cell and Molecular Biology, cartea 370

Fernando Aranda Vega, Pedro Berraondo, Lorenzo Galluzzi
en Limba Engleză Hardback – 7 iul 2022
Adoptive Cell Transfer, Volume 370 in the International Review of Cell and Molecular Biology series highlights advances in the field, with this new volume presenting interesting chapters written by an international board of authors who expound on topics such as the Impact of tumor microenvironment on Adoptive Cell Transfer activity, Dendritic Cell Transfer, CAR-T Cell dysfunction and exhaustion, NK Cell-based cancer immunotherapy, Enabling CAR-T cells for solid tumors: rage against the suppressive tumor microenvironment, Improving Adoptive T-Cell therapy with cytokines administration, and What will (and should) be improved in Immunotherapy with CAR?

  • Publishes only invited review articles on selected topics
  • Authored by established and active cell and molecular biologists and drawn from international sources
  • Offers a wide range of perspectives on specific subjects
Citește tot Restrânge

Din seria International Review of Cell and Molecular Biology

Preț: 95530 lei

Preț vechi: 133113 lei
-28% Nou

Puncte Express: 1433

Preț estimativ în valută:
18279 19085$ 15129£

Carte tipărită la comandă

Livrare economică 29 martie-12 aprilie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323993999
ISBN-10: 0323993990
Pagini: 204
Dimensiuni: 152 x 229 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Seria International Review of Cell and Molecular Biology


Public țintă

Academic, government and industrial sectors

Cuprins

1. Impact of tumor microenvironment on Adoptive Cell Transfer activity
Juan Jose Lasarte
2. Dendritic Cell Transfer
Oliver Kepp
3. CAR-T Cell dysfunction and exhaustion
Angela Aznar
4. NK Cell-based cancer immunotherapy
Maite Alvarez
5. Enabling CAR-T cells for solid tumors: rage against the suppressive tumor microenvironment
Asís Palazon
6. Improving Adoptive T-Cell therapy with cytokines administration
Jonathan Pol
7. What will (and should) be improved in Immunotherapy with CAR?
M Juan